Goals of care designations in advanced pancreatic cancer patients undergoing palliative chemotherapy.

Authors

null

Matthew Anaka

University of Alberta, Edmonton, AB, Canada

Matthew Anaka , Minji Lee , Elisa Lim , Sunita Ghosh , Winson Y. Cheung , Jennifer L. Spratlin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Quality of Care/Quality Improvement

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 683)

Abstract #

683

Poster Bd #

J14

Abstract Disclosures

Similar Posters

First Author: Sangyang Jia

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Efficacy of the third-line chemotherapy in patients with advanced pancreatic cancer.

Efficacy of the third-line chemotherapy in patients with advanced pancreatic cancer.

First Author: Bomi Kim

First Author: Matthew Anaka

Poster

2017 Palliative and Supportive Care in Oncology Symposium

Do hospitalized cancer patients requiring palliative care consultation discharged to subacute rehabilitation ever get anticancer therapy again?

Do hospitalized cancer patients requiring palliative care consultation discharged to subacute rehabilitation ever get anticancer therapy again?

First Author: Muhammad Azeem Khan